Latest Clinical trials News
23andMe cuts 40% of its workforce and discontinues therapeutics division
NEW YORK (AP) — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the struggling genetic testing company attempts to slash costs. The latest restructuring efforts were announced by 23andMe on Monday. The company...
Rwanda will deploy Marburg vaccine under trial as death toll rises to 12
KIGALI, Rwanda (AP) — Rwandan health authorities will begin a vaccine study against the Marburg hemorrhagic fever, officials said Sunday, as the East African country tries to stop the spread of an outbreak that has killed 12 people. Rwanda, which received 700 doses of a vaccine...
Some California stem cell clinics use unproven therapies. A new court ruling cracks down
Stem cell clinics have popped up throughout California, promising cures and relief for arthritis, Alzheimer’s and other conditions through cutting-edge technologies. Some, however, are offering services that have not been approved by federal health regulators. The U.S. Food and...
Rwanda's Marburg fever deaths rise to 11 as its source is being investigated
KIGALI, Rwanda (AP) — Marburg hemorrhagic fever has killed 11 people in Rwanda, health authorities said Thursday, as the East African country searches for the source of an outbreak first traced among patients in health facilities. There are 36 confirmed cases of the disease that...
Drugmaker Lilly slates another $4.5B for manufacturing and drug development improvements
INDIANAPOLIS (AP) — Eli Lilly is pouring another $4.5 billion into expanding manufacturing and development as the drugmaker rakes in billions from new product sales. The diabetes treatment maker said Wednesday that it will build a new center for advanced manufacturing and drug...
Congress targets Chinese influence in health tech. It could come with tradeoffs
WASHINGTON (AP) — A California biotechnology company that helps doctors detect genetic causes for cancer is among those that could be cut out of the U.S. market over ties to China, underscoring the possible tradeoffs between health innovation and a largely bipartisan push in Congress to counter...
Congress takes up a series of bills targeting China, from drones to drugs
WASHINGTON (AP) — How to curb and counter China's influence and power — through its biotech companies, drones and electric vehicles — will dominate the U.S. House's first week back from summer break, with lawmakers taking up a series of measures targeting Beijing. Washington...
